Lactobacillus rhamnosus reduces CD8+T cell mediated inflammation in patients with rheumatoid arthritis

Background: The T cells, components of adaptive immunity participate in immune pathology of the autoimmune inflammatory disorder called rheumatoid arthritis (RA). The presence of TLRs on the surface of the CD8(+) T cells and their ability to recognize bacterial moieties adds to the inflammatory burden in case of RA. It has been reported that the gut microbiome is necessary for the crucial shift in the balance between proinflammatory and anti-inflammatory cytokines. The altered gut microbiome and the presence of TLRs emphasizes on the microbiome driven inflammatory responses in case of RA. Methods: Eighty-nine RA patients participated in this study. Clinical variations like disease duration, number of actively inflamed joints, number and type of bone deformities, CRP, RF, Anti-CCP, ESR, DAS 28 score were recorded for each patient. Co-culture of CD8(+)T cells and bacteria has been performed with proper culture condition. TLRs and inflammatory mediators' expression level were checked by both qPCR and flow cytometry analysis. Results: We observed in the suppression of pro-inflammatory molecules like Granzyme B and IFN gamma and expression of TLR2 in CD8 + T cells upon treatment with Lactobacillus rhamnosus (L. rhamnosus). Moreover, L. rhamnosus activated CD8(+)T cells such that they could induce FOXP3 expression in CD4(+)T cells thereby skewing T cell population towards a regulatory phenotype. On the contrary, TLR4 engagement on CD8(+)T cell by Escherichia coli (E.coli) increased in inflammatory responses following ERK activation. Conclusions: Thus, we conclude that L. rhamnosus can effectively suppress CD8(+)T cell mediated inflammation by a simultaneous decrease of Th1 cells that may potentiate better treatment modalities for RA.